Clinical trials recruiting in Hastings, Nebraska
6
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 4Not applicable 2
Conditions recruiting in Hastings, Nebraska
Recruiting trials in Hastings, Nebraska
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Integrated Cancer Repository for Cancer Research
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Common questions
How many clinical trials are recruiting in Hastings, Nebraska?
6 recruiting trials have at least one study site in Hastings, Nebraska.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.